NCT01374282No Longer Available不适用
Post Marketing Surveillance Study of Cuprimine (MK-0172-001)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
研究概览
简要总结
Cuprimine (penicillamine) was made available in the Philippines by the Sponsor under a Compassionate Special Permit issued by the Bureau of Food and Drugs. Physicians were able to request the drug for their patients from the Sponsor. A Clinical Study Report form was completed for each purchase of Cuprimine.
研究设计
- 研究类型
- Expanded Access
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic PatientsSchizophreniaNCT01819818Janssen Korea, Ltd., Korea3,267
已完成
不适用
Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent)Vaccines, Pneumococcal Conjugate VaccineNCT00683410Wyeth is now a wholly owned subsidiary of Pfizer3,366
已完成
不适用
Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 DisorderBipolar 1 DisorderSchizophreniaNCT03386851Korea Otsuka Pharmaceutical Co., Ltd.1,030
已完成
不适用
Eliquis Regulatory Post Marketing Surveillance (rPMS)Venous ThromboembolismNCT01885585Bristol-Myers Squibb100
进行中（未招募）
不适用
Iclusig PMS in CML or Ph+ALL PatientsChronic Myeloid LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic LeukemiaNCT03709017Korea Otsuka Pharmaceutical Co., Ltd.50